Abiraterone
The serum concentration of Trabectedin can be increased when it is combined with Abiraterone.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Trabectedin.
Amiodarone
The serum concentration of Trabectedin can be increased when it is combined with Amiodarone.
Advertisement
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Trabectedin.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Trabectedin.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Trabectedin is combined with Anthrax immune globulin human.
Advertisement
Apalutamide
The serum concentration of Trabectedin can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Trabectedin can be increased when it is combined with Aprepitant.
Armodafinil
The metabolism of Trabectedin can be decreased when combined with Armodafinil.
Advertisement
Artemether
The metabolism of Trabectedin can be decreased when combined with Artemether.
Atazanavir
The serum concentration of Trabectedin can be increased when it is combined with Atazanavir.
Atomoxetine
The metabolism of Trabectedin can be decreased when combined with Atomoxetine.
Atorvastatin
Atorvastatin may increase the myopathic rhabdomyolysis activities of Trabectedin.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Trabectedin.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Trabectedin is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Trabectedin is combined with Bacillus calmette-guerin substrain tice live antigen.
Betaxolol
The metabolism of Trabectedin can be decreased when combined with Betaxolol.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Trabectedin.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Trabectedin.
Boceprevir
The serum concentration of Trabectedin can be increased when it is combined with Boceprevir.
Bortezomib
The metabolism of Trabectedin can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Trabectedin can be decreased when it is combined with Bosentan.
Bupropion
The metabolism of Trabectedin can be decreased when combined with Bupropion.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Trabectedin.
Capecitabine
The metabolism of Trabectedin can be decreased when combined with Capecitabine.
Carbamazepine
The serum concentration of Trabectedin can be decreased when it is combined with Carbamazepine.
Celecoxib
The metabolism of Trabectedin can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Trabectedin can be increased when it is combined with Ceritinib.
Cerivastatin
Cerivastatin may increase the myopathic rhabdomyolysis activities of Trabectedin.
Chloramphenicol
The metabolism of Trabectedin can be decreased when combined with Chloramphenicol.
Chloroquine
The metabolism of Trabectedin can be decreased when combined with Chloroquine.
Chlorpromazine
The metabolism of Trabectedin can be decreased when combined with Chlorpromazine.
Cholecalciferol
The metabolism of Trabectedin can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Trabectedin can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Trabectedin can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Trabectedin can be decreased when combined with Citalopram.
Clarithromycin
The serum concentration of Trabectedin can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Trabectedin can be decreased when combined with Clemastine.
Clobazam
The metabolism of Trabectedin can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Trabectedin can be decreased when combined with Clomipramine.
Clotrimazole
The metabolism of Trabectedin can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Trabectedin is combined with Clozapine.
Cobicistat
The serum concentration of Trabectedin can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Trabectedin can be decreased when combined with Cocaine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Trabectedin.
Crisaborole
The metabolism of Trabectedin can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Trabectedin can be decreased when combined with Crizotinib.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Trabectedin.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Trabectedin.
Cyclosporine
The metabolism of Trabectedin can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The serum concentration of Trabectedin can be decreased when it is combined with Cyproterone acetate.
Dabrafenib
The serum concentration of Trabectedin can be decreased when it is combined with Dabrafenib.
Darifenacin
The metabolism of Trabectedin can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Trabectedin can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Trabectedin can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Trabectedin can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Trabectedin can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Trabectedin can be decreased when combined with Delavirdine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Trabectedin.
Desipramine
The metabolism of Trabectedin can be decreased when combined with Desipramine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Trabectedin.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Trabectedin.
Digoxin
Digoxin may decrease the cardiotoxic activities of Trabectedin.
Dihydroergotamine
The metabolism of Trabectedin can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Trabectedin can be decreased when combined with Diltiazem.
Diphenhydramine
The metabolism of Trabectedin can be decreased when combined with Diphenhydramine.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Trabectedin.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Trabectedin.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Trabectedin.
Dothiepin
The metabolism of Trabectedin can be decreased when combined with Dosulepin.
Doxycycline
The metabolism of Trabectedin can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Trabectedin can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Trabectedin can be decreased when combined with Dronedarone.
Duloxetine
The metabolism of Trabectedin can be decreased when combined with Duloxetine.
Efavirenz
The metabolism of Trabectedin can be decreased when combined with Efavirenz.
Eliglustat
The metabolism of Trabectedin can be decreased when combined with Eliglustat.
Enzalutamide
The serum concentration of Trabectedin can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Trabectedin can be decreased when combined with Erythromycin.
Eslicarbazepine Acetate
The metabolism of Trabectedin can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Trabectedin can be decreased when combined with Esomeprazole.
Ethanol
Ethanol may increase the hepatotoxic activities of Trabectedin.
Etravirine
The metabolism of Trabectedin can be decreased when combined with Etravirine.
Fingolimod
Trabectedin may increase the immunosuppressive activities of Fingolimod.
Floxuridine
The metabolism of Trabectedin can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Trabectedin can be decreased when combined with Fluconazole.
Fluorouracil
The metabolism of Trabectedin can be decreased when combined with Fluorouracil.
Fluoxetine
The metabolism of Trabectedin can be decreased when combined with Fluoxetine.
Fluvastatin
Fluvastatin may increase the myopathic rhabdomyolysis activities of Trabectedin.
Fluvoxamine
The metabolism of Trabectedin can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Trabectedin can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Trabectedin can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Trabectedin can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Trabectedin can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Trabectedin can be increased when it is combined with Fusidic Acid.
Gemfibrozil
The metabolism of Trabectedin can be decreased when combined with Gemfibrozil.
Haloperidol
The metabolism of Trabectedin can be decreased when combined with Haloperidol.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Trabectedin is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Trabectedin is combined with Hepatitis B Vaccine (Recombinant).
Hypoxis hemerocallidea root extract
The serum concentration of Trabectedin can be decreased when it is combined with St. John's Wort.
Idelalisib
The serum concentration of Trabectedin can be increased when it is combined with Idelalisib.
Imatinib
The metabolism of Trabectedin can be decreased when combined with Imatinib.
Imipramine
The metabolism of Trabectedin can be decreased when combined with Imipramine.
Indinavir
The serum concentration of Trabectedin can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Trabectedin can be increased when it is combined with Indinavir.
Irbesartan
The metabolism of Trabectedin can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Trabectedin can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Trabectedin can be decreased when combined with Isavuconazonium.
Isoniazid
The metabolism of Trabectedin can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Trabectedin can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Trabectedin can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Trabectedin can be increased when it is combined with Ivacaftor.
Ketoconazole
The serum concentration of Trabectedin can be increased when it is combined with Ketoconazole.
Leflunomide
The risk or severity of adverse effects can be increased when Trabectedin is combined with Leflunomide.
Lopinavir
The serum concentration of Trabectedin can be increased when it is combined with Lopinavir.
Lorcaserin
The metabolism of Trabectedin can be decreased when combined with Lorcaserin.
Losartan
The metabolism of Trabectedin can be decreased when combined with Losartan.
Lovastatin
Lovastatin may increase the myopathic rhabdomyolysis activities of Trabectedin.
Luliconazole
The serum concentration of Trabectedin can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Trabectedin can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Trabectedin can be decreased when combined with Lumefantrine.
Manidipine
The metabolism of Trabectedin can be decreased when combined with Manidipine.
Methadone
The metabolism of Trabectedin can be decreased when combined with Methadone.
Methotrimeprazine
The metabolism of Trabectedin can be decreased when combined with Methotrimeprazine.
Metoprolol
The metabolism of Trabectedin can be decreased when combined with Metoprolol.
Midostaurin
The serum concentration of Trabectedin can be increased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Trabectedin can be increased when it is combined with Mifepristone.
Mirabegron
The metabolism of Trabectedin can be decreased when combined with Mirabegron.
Mitotane
The serum concentration of Trabectedin can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Trabectedin can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Trabectedin can be decreased when combined with Modafinil.
Natalizumab
The risk or severity of adverse effects can be increased when Trabectedin is combined with Natalizumab.
Nefazodone
The serum concentration of Trabectedin can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Trabectedin can be increased when it is combined with Nelfinavir.
Netupitant
The serum concentration of Trabectedin can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Trabectedin can be decreased when it is combined with Nevirapine.
Nicardipine
The metabolism of Trabectedin can be decreased when combined with Nicardipine.
Nicotine
The metabolism of Trabectedin can be decreased when combined with Nicotine.
Nicotine Polacrilex
The metabolism of Trabectedin can be decreased when combined with Nicotine.
Nilotinib
The metabolism of Trabectedin can be decreased when combined with Nilotinib.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Trabectedin.
Olaparib
The metabolism of Trabectedin can be decreased when combined with Olaparib.
Omeprazole
The metabolism of Trabectedin can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Trabectedin can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Trabectedin.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Trabectedin.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Trabectedin.
Palbociclib
The serum concentration of Trabectedin can be increased when it is combined with Palbociclib.
Panobinostat
The serum concentration of Trabectedin can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Trabectedin can be decreased when combined with Pantoprazole.
Paroxetine
The metabolism of Trabectedin can be decreased when combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Trabectedin can be decreased when it is combined with Peginterferon alfa-2b.
Pentobarbital
The serum concentration of Trabectedin can be decreased when it is combined with Pentobarbital.
Phenobarbital
The serum concentration of Trabectedin can be decreased when it is combined with Phenobarbital.
Phenytoin
The serum concentration of Trabectedin can be decreased when it is combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trabectedin.
Pitavastatin
Pitavastatin may increase the myopathic rhabdomyolysis activities of Trabectedin.
Posaconazole
The serum concentration of Trabectedin can be increased when it is combined with Posaconazole.
Pravastatin
Pravastatin may increase the myopathic rhabdomyolysis activities of Trabectedin.
Primidone
The serum concentration of Trabectedin can be decreased when it is combined with Primidone.
Promazine
The metabolism of Trabectedin can be decreased when combined with Promazine.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Trabectedin.
Pyrimethamine
The metabolism of Trabectedin can be decreased when combined with Pyrimethamine.
Quinidine
The metabolism of Trabectedin can be decreased when combined with Quinidine.
Quinine
The metabolism of Trabectedin can be decreased when combined with Quinine.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Trabectedin is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Trabectedin is combined with Rabies virus inactivated antigen, A.
Ranolazine
The metabolism of Trabectedin can be decreased when combined with Ranolazine.
Rifabutin
The serum concentration of Trabectedin can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Trabectedin can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Trabectedin can be decreased when it is combined with Rifapentine.
Ritonavir
The metabolism of Trabectedin can be decreased when combined with Ritonavir.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Trabectedin.
Rolapitant
The metabolism of Trabectedin can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Trabectedin can be decreased when combined with Ropinirole.
Rosuvastatin
Rosuvastatin may increase the myopathic rhabdomyolysis activities of Trabectedin.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Trabectedin is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Trabectedin is combined with Rubella virus vaccine.
Rucaparib
The metabolism of Trabectedin can be decreased when combined with Rucaparib.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Trabectedin is combined with Salmonella typhi ty21a live antigen.
Saquinavir
The serum concentration of Trabectedin can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Trabectedin can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Trabectedin can be decreased when used in combination with Sarilumab.
Secobarbital
The metabolism of Trabectedin can be increased when combined with Secobarbital.
Sertraline
The metabolism of Trabectedin can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Trabectedin can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Trabectedin can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Trabectedin can be increased when it is combined with Simeprevir.
Simvastatin
Simvastatin may increase the myopathic rhabdomyolysis activities of Trabectedin.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Trabectedin.
Sorafenib
The metabolism of Trabectedin can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Trabectedin can be decreased when it is combined with St. John's Wort.
Sulfadiazine
The metabolism of Trabectedin can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Trabectedin can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Trabectedin can be decreased when combined with Sulfisoxazole.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Trabectedin.
Telaprevir
The serum concentration of Trabectedin can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Trabectedin can be increased when it is combined with Telithromycin.
Terbinafine
The metabolism of Trabectedin can be decreased when combined with Terbinafine.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Trabectedin is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Thioridazine
The metabolism of Trabectedin can be decreased when combined with Thioridazine.
Ticagrelor
The metabolism of Trabectedin can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Trabectedin can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Trabectedin can be decreased when combined with Tipranavir.
Tocilizumab
The serum concentration of Trabectedin can be decreased when it is combined with Tocilizumab.
Tofacitinib
Trabectedin may increase the immunosuppressive activities of Tofacitinib.
Tolbutamide
The metabolism of Trabectedin can be decreased when combined with Tolbutamide.
Topiramate
The metabolism of Trabectedin can be decreased when combined with Topiramate.
Tranylcypromine
The metabolism of Trabectedin can be decreased when combined with Tranylcypromine.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Trabectedin.
Trimethoprim
The metabolism of Trabectedin can be decreased when combined with Trimethoprim.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Trabectedin is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Trabectedin is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Valproate
The metabolism of Trabectedin can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Trabectedin can be decreased when combined with Valproic Acid.
Valsartan
The metabolism of Trabectedin can be decreased when combined with Valsartan.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Trabectedin is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vemurafenib
The serum concentration of Trabectedin can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Trabectedin can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Trabectedin can be decreased when combined with Verapamil.
Voriconazole
The serum concentration of Trabectedin can be increased when it is combined with Voriconazole.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Trabectedin is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Trabectedin is combined with Yellow Fever Vaccine.
Zafirlukast
The metabolism of Trabectedin can be decreased when combined with Zafirlukast.
Ziprasidone
The metabolism of Trabectedin can be decreased when combined with Ziprasidone.
